News

Reg Med Net
regmednet. com > cell-therapy-weekly-worlds-first-b-cell-therapy-administered-to-pediatric-patient

Cell therapy weekly: world's first B-cell therapy administered to pediatric patient

4+ hour, 44+ min ago  (462+ words) Reg Med Net is part of Taylor & Francis Group. The therapy aims to overcome the limitations of current enzyme replacement therapy infusions and address safety concerns associated with stem cell therapy. ISP-001 utilizes the patient's own B cells to produce…...

Reg Med Net
regmednet. com > reconnecting-spinal-circuits-neural-progenitor-cell-transplantation-shows-promise-for-spinal-cord-injury

Reconnecting spinal circuits: neural progenitor cell transplantation shows promise for spinal cord injury

1+ day, 5+ hour ago  (333+ words) Reg Med Net is part of Taylor & Francis Group. Neural progenitor cells with the ability to establish motor circuit connections in spinal cord injuries have been identified. A recent study, conducted by researchers at Texas A&M University (TX, USA),…...

Reg Med Net
regmednet. com > cell-therapy-weekly-fast-track-designation-for-solid-tumor-car-t-therapy

Cell therapy weekly: Fast Track designation for solid tumor CAR-T therapy

6+ day, 23+ hour ago  (219+ words) Reg Med Net is part of Taylor & Francis Group. This week: Ray Therapeutics (CA, USA) received Regenerative Medicine Advanced Therapy (RMAT) designation for its gene therapy candidate for retinitis pigmentosa, A2 Biotherapeutics (CA, USA) received Fast Track designation for its CAR-T…...

Reg Med Net
regmednet. com > spotlights > spt_raw_pc_spotlight-on-raw-materials-and-supply-chain_promocell

Spotlight on raw materials and supply chain

6+ day, 21+ hour ago  (181+ words) regmednet. com Reg Med Net is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at…...

Reg Med Net
regmednet. com > spt_raw_pc_raw-materials-and-supply-chain-take-the-survey_promocell

Raw materials and supply chain: take the survey!

6+ day, 21+ hour ago  (173+ words) As part of our Spotlight on raw materials and supply chain, we invite you to share your'expertise'and experiences in this survey, which focuses on the key factors influencing raw material'selection, supply chain management, and the transition to clinical manufacturing. Your…...

Reg Med Net
regmednet. com > uncomfortable-questions-advanced-therapies-must-confront-as-they-mature

Uncomfortable questions advanced therapies must confront as they mature

1+ week, 1+ day ago  (85+ words) Reg Med Net Reg Med Net is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address…...

Reg Med Net
regmednet. com > regenerative-medicine-highlights-january-march-2026

Regenerative Medicine Highlights: January - March 2026

1+ week, 2+ day ago  (60+ words) Regenerative Medicine Highlights: January " March 2026 Reg Med Net Reg Med Net is part of Taylor & Francis Group. Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK…...

Reg Med Net
regmednet. com > fda-approves-lad-i-gene-therapy

FDA approves LAD-I gene therapy

1+ week, 2+ day ago  (538+ words) Reg Med Net is part of Taylor & Francis Group. Original story from UCLA Health (CA, USA). The US Food and Drug Administration (FDA; MD, USA) has approved Rocket Pharmaceutical's (NJ, USA)" gene therapy, Kresladi, for severe leukocyte adhesion deficiency-I. Donald…...

Reg Med Net
regmednet. com > agerea-a-potential-breakthrough-tool-for-transforming-stem-cell-applications

Agerea: a potential breakthrough tool for transforming stem cell applications

1+ week, 5+ day ago  (414+ words) Reg Med Net is part of Taylor & Francis Group. Original story from Texas A&M University (TX, USA). Researchers have developed a tool, Agerea, to address stem cell clumping, which has long hindered advancements in regenerative medicine. When stem cells…...

Reg Med Net
regmednet. com > cell-therapy-weekly-biotech-emerges-from-stealth-with-parkinsons-disease-program

Cell therapy weekly: biotech emerges from stealth with Parkinson's disease program

1+ week, 6+ day ago  (348+ words) Reg Med Net is part of Taylor & Francis Group. Emerging from stealth, clinical-stage biotechnology company Oryon Cell Therapies (CA, USA) is on track to complete the ongoing Phase Ib/IIa clinical trial of its neuron replacement therapy program for Parkinson's…...